CTLA4 and breast cancer: However, hsa-mir-92a has not been reported in breast cancer.In our study, we hypothesized that CTLA-4 in TNBC can be regulated by hsa-mir-92a which forms ceRNA network through the above biological pathways and affects the prognosis of TNBC patients.